Maria L. Amaya - Concepedia

Author

Maria L. Amaya

University of Colorado Denver ORCID

Also Known As

Amaya, M.L., Amaya, Maria, Christine McMahon, M. Amaya, Maria Amaya, Maria L Amaya, Maria L. Amaya, Maria Laura Amaya

161

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver University of Colorado Anschutz Medical Campus The University of Texas Southwestern Medical Center Cincinnati Children's Hospital Medical Center Memorial Sloan Kettering Cancer Center

About

Maria L. Amaya is an author at University of Colorado Denver specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.1K
2	Pharmacology	5	5	1.1K
3	Health Sciences	3	3	756
4	Cell Biology	3	3	756
5	Immunology	3	3	720

Maria L. Amaya

Publications

Citations

H-Index

Page 1

	Year	Citations
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia Shanshan Pei, Daniel A. Pollyea, Annika Gustafson, Cancer Discovery Mixed-phenotype Acute LeukemiaImmunologyPharmacotherapyImmunotherapyDrug Resistance	2020	518
Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells Courtney L. Jones, Brett M. Stevens, Daniel A. Pollyea, Cell stem cell Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaStem CellsHematology	2020	216
<i>Trypanosoma c</i><i>ruzi</i> Trans-sialidase Operates through a Covalent Sialyl−Enzyme Intermediate: Tyrosine Is the Catalytic Nucleophile Andrew G. Watts, Iben Damager, Maria L. Amaya, Journal of the American Chemical Society	2003	207
Venetoclax for AML: changing the treatment paradigm Daniel A. Pollyea, Maria L. Amaya, Paolo Strati, Blood Advances Hematological MalignancyOncologyVenetoclax-based TherapiesMixed-phenotype Acute LeukemiaAcute Myeloid Leukemia	2019	162
Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia Evan Cherry, Diana Abbott, Maria L. Amaya, Blood Advances Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematology	2021	160
p66α–MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2–NuRD complex Merlin Nithya Gnanapragasam, J.N. Scarsdale, Maria L. Amaya, Proceedings of the National Academy of Sciences	2011	143
The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation Maria L. Amaya, Anagha Inguva Sheth, Shanshan Pei, Blood	2021	122
Mi2β-mediated silencing of the fetal γ-globin gene in adult erythroid cells Maria L. Amaya, Megha Desai, Merlin Nithya Gnanapragasam, Blood	2013	110
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology Neil P. Shah, Ravi Bhatia, Jessica K. Altman, Journal of the National Comprehensive Cancer Network	2024	96
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy Shanshan Pei, Ian T. Shelton, Austin E. Gillen, Cancer Discovery	2023	86

Page 1